Centre Europeen de Repartition Pharmaceuti… SA
243.9 FTECentre Europeen de Repartition Pharmaceuti… reported revenue of €580.7m for the 2025 financial year (annual accounts filed with the NBB on 09 Jun 2026), with 243.9 full-time equivalents.
By total assets for 2025, Centre Europeen de Repartition Pharmaceuti… ranks among the 50 largest of the 970 companies in its sector (NACE 4646) in Belgium that filed accounts for that financial year. Largest companies in the sector →
The score of Centre Europeen de Repartition Pharmaceuti… shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Revenue +40 % Equity 0 % Total assets +22 % Headcount (avg FTE) +9 %
Accounts of the company itself (not consolidated).
The full file covers 18 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Centre Europeen de Repartition Pharmaceuti…'s annual accounts
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Revenue | €580.7m | ||||
| Net result | −264,144 € | ||||
| Equity | €11.6m | ||||
| Cash | €2.44m | ||||
| EBITDA | €2.81m | ||||
| Total assets | €127.7m |
Filed annual accounts
- Year ended 31 Dec 2025filed on 09 Jun 2026
- Year ended 31 Dec 2024filed on 10 Jun 2025
- Year ended 31 Dec 2023filed on 31 May 2024
- Year ended 31 Dec 2022filed on 08 Jun 2023
- Year ended 31 Dec 2021filed on 02 Jun 2022
Centre Europeen de Repartition Pharmaceuti…'s financial analysis
- Solvency9.1%sector median: 32.3%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Centre Europeen de Repartition Pharmaceuti…
8 active director(s) in the register.
and 2 more
Centre Europeen de Repartition Pharmaceuti…'s shareholders and holdings →Centre Europeen de Repartition Pharmaceuti…'s publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0403.057.962
- VAT number
- BE0403057962
- Peppol
- Registered · 0208:0403057962 · as of 14 Nov 2026
- Legal form
- SA
- Incorporated
- 01 Jan 1968
- Registered office
- 1070 Anderlecht
- Size
- Medium · 243.9 FTE
- Latest accounts
- 2025 · filed on 09 Jun 2026
- Activity
- Wholesale of pharmaceutical and medical goods (NACE 46460)
Centre Europeen de Repartition Pharmaceuti… (SA) has been based in Anderlecht since 1968, active in: wholesale of pharmaceutical and medical goods. For 2025, it reports revenue of €580.7m, a net loss of 264,144 € and equity of €11.6m. With 243.9 full-time equivalents, it is a medium-sized enterprise by headcount.
Guide: Checking a Belgian supplier invoice: numbers and IBAN →
Companies similar to Centre Europeen de Repartition Pharmaceuti…
Companies in the same business, of comparable size and area, outside its group.
- Gilead Sciences Belgium Wholesale of pharmaceutical and medical goods Machelen (Brab.) · balance sheet €68.7m
- sandoz Wholesale of pharmaceutical and medical goods Machelen (Brab.) · balance sheet €55.3m
- Servier Benelux Wholesale of pharmaceutical and medical goods Anderlecht · balance sheet €61.5m
- Takeda Belgium Wholesale of pharmaceutical and medical goods Zaventem · balance sheet €86.4m
- Haleon Belgium Wholesale of pharmaceutical and medical goods Zaventem · balance sheet €29.4m
- Omrix Biopharmaceuticals Wholesale of pharmaceutical and medical goods Machelen (Brab.) · balance sheet €66.5m
- EG Wholesale of pharmaceutical and medical goods Brussels · balance sheet €113.6m
- Janssen-Cilag Wholesale of pharmaceutical and medical goods Beerse · balance sheet €188.0m
Frequently asked questions about Centre Europeen de Repartition Pharmaceuti…
What is the revenue of Centre Europeen de Repartition Pharmaceuti…?
According to the 2025 annual accounts filed with the NBB, the revenue of Centre Europeen de Repartition Pharmaceuti… amounts to 580,721,056 €.
What is the VAT number of Centre Europeen de Repartition Pharmaceuti…?
In Belgium, the VAT number is the company number prefixed with BE: BE0403057962 for Centre Europeen de Repartition Pharmaceuti…, if the company is VAT-registered. Its company number (CBE) is 0403.057.962.
Where is the registered office of Centre Europeen de Repartition Pharmaceuti…?
According to the CBE register, the registered office of Centre Europeen de Repartition Pharmaceuti… is in 1070 Anderlecht.
What is the equity of Centre Europeen de Repartition Pharmaceuti…?
At the close of the 2025 financial year, the equity of Centre Europeen de Repartition Pharmaceuti… amounts to 11,617,699 €, a solvency of 9.1% of total assets.
How many people work at Centre Europeen de Repartition Pharmaceuti…?
243.9 full-time equivalents on average according to the 2025 social balance sheet.
Who manages Centre Europeen de Repartition Pharmaceuti…?
The register lists 8 active mandates at Centre Europeen de Repartition Pharmaceuti…. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
How large is Centre Europeen de Repartition Pharmaceuti… within its sector?
By total assets for 2025, Centre Europeen de Repartition Pharmaceuti… ranks among the 50 largest of the 970 companies in its sector (NACE 4646) in Belgium that filed accounts for that financial year.
The full file of Centre Europeen de Repartition Pharmaceuti…
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →